New bioRxiv paper showcases: Tumor-informed ctDNA detection down to one-in-ten million (10-7), which extends well beyond the limits of currently available clinical minimal residual disease (MRD) assays Superior double-stranded DNA (dsDNA) recovery rates versus other technologies, reducing...
Hence then, the article about ultima genomics ppmseq delivers unmatched combination of sensitivity and efficiency for whole genome mrd detection was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Ultima Genomics' ppmSeq™ Delivers Unmatched Combination of Sensitivity and Efficiency for Whole-Genome MRD Detection )
Also on site :
- AI in Clinical Trials Market to Reach USD 7.32 Billion by 2034 as AI Reshapes Patient Recruitment, Data Analysis and Drug Development, says Maximize Market Research
- Comviva beruft Jeet Singh zur Förderung von globalem Wachstum, Transformation und strategischen Partnerschaften
- FDIC Appoints Sunwest Bank as Nano Banc's Acquiring Institution